Leerink Partners Research is Now Available in S&P Global’s Aftermarket Research Collection

We are pleased to announce that Leerink Partners, a leading US Investment Bank specializing in deep sector investment research across Healthcare, is now available in the S&P Global Aftermarket Research collection. 

With an average senior experience of 15+ years, analysts at Leerink Partners cover more than 300 companies, providing detailed financial forecasts, in-depth opinions on strategy and market trends, and expert valuations. Leerink analysts cover Healthcare across segments, including Biotechnology, Pharmaceuticals, and Life Science Services, as well as Healthcare equipment, technology and facilities.

Founded in 1995, Leerink Partners is headquartered in Boston with offices across the US and the UK. The following year, the firm established MEDACorp, an expert network acting as a strategic knowledge resource for Leerink, validing new products and company commercial viability.

Leerink Partners research has been available on S&P Global platforms on a Real-Time Research basis to approved clients since 2006, with more than 53,000+ reports available. The entire collection is now accessible to S&P Global clients with an Aftermarket Research license.

Leerink Partners adds further value to our Aftermarket Research collection, which contains more than 40 million reports from more than 1,800 investment banks and independent research providers, including J.P. Morgan, UBS, Jefferies, Barclays, Citigroup – and now Leerink Partners.

The S&P Global Aftermarket Research offering continues to expand, providing greater coverage of companies and industries globally. Over the past 12 months, S&P welcomed more than 45 new Aftermarket Research contributors, including Bernstein, Stephens, Mizuho USA, Santander, and Kepler Cheuvreux.